03.07.17

Theranica Raises $6 Million to Combat Migraine

NETANYA, Israel, July 3, 2017 / PRNewswire

Theranica Bio-Electronics, a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases, announced the closing of its round A of financing, led by Lightspeed Venture Partners. Other investors participating in the round are LionBird venture capital firm and Corundum Open Innovation.

The funds, totaling about $6M will be used mainly to complete the regulatory process of the company's first product, for acute treatment of migraine, and to bring the product to mass production.

Join Our Mailing ListSign up to receive regular updates from our blog and news about Viola